			Home About us Contact

French Children (french + child)

Distribution by Scientific Domains

Medical Sciences	100%

Selected Abstracts

Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy

PEDIATRIC ALLERGY AND IMMUNOLOGY, Issue 8 2006
Vasilisa Sazonov-Kocevar
As observational studies in children initiating GINA-Step 3 therapies are scarce, we evaluated outcomes and costs in a primary care cohort. Two-yr retrospective cohort study included French children (age: 6,14) continuously followed in BKL-Thalès database who received ,2 consecutive prescriptions for GINA-Step 3 therapy (=addition of montelukast or other controllers (,other'), such as increasing inhaled-corticosteroid dose (hICS), adding long-acting , agonist (LABA), or ICS + LABA). After matching on gender and propensity score, medication use [rescue (short-acting , agonists), acute (antibiotics (AB), oral corticosteroids (OCS)), allergy (antihistamines, nasal steroids) and other respiratory] was estimated via mean number of prescriptions and mean cost (per child/per month), and cost trends. During 12-month follow-up, children adding montelukast (n = 71) vs. ,other' (n = 213) had similar asthma rescue/acute and allergy medication use. Subgroup with asthma and allergic rhinitis (A + AR) adding montelukast used less OCS and AB (p = 0.014). Two-yr cost trends suggest stable asthma/allergy medication use in montelukast group (,0.83) compared with increase in ,other' (,5.39), which was driven by nasal steroid use [,0.32 (,other') vs. ,,0.04 (montelukast), p = 0.0013]. In subgroup with A + AR decline in asthma/allergy medication use in montelukast group (,,0.47) vs. increase in ,other' (,11.05), p = 0.015, was driven by differences in AB and OCS (p = 0.04) and nasal steroid use (p = 0.001). Concomitant asthma/allergy medication use was similar in children adding montelukast or ,other' controllers (hICS, LABA, ICS + LABA), while children with allergic rhinitis on montelukast used less AB. Concomitant medication costs after addition of montelukast remained stable, while ,other' group experienced increase, especially in children with concomitant allergic rhinitis. [source]

Sensitization and allergy to turnip rape: a comparison between the Finnish and French children with atopic dermatitis

ACTA PAEDIATRICA, Issue 2 2009
S Poikonen
Abstract Aim: Finnish children with atopic dermatitis (AD) are frequently sensitized and show positive food challenge to turnip rape. We examined whether French children are also allergic to this oilseed plant and whether mustard could be the cross-reacting allergen. Methods: Turnip rape and mustard challenge was performed to 14 Finnish and 14 French children with atopic dermatitis and positive skin prick test to turnip rape. Specific IgE antibodies were measured by ImmunoCAP and enzyme-linked immunosorbent assay (ELISA). Results: Open labial or oral challenge to turnip rape was positive in 14 (100%) Finnish and five (36%) French children and mustard challenge in five Finnish and five French children. IgE antibodies to oilseed rape and mustard were slightly more frequent in the Finnish (100% and 93%) than in the French (93% and 71%) children but rare (4%) in the 28 matched controls. The same findings were true for IgE antibodies to purified 2S albumin allergens, which showed similar cross-wise IgE inhibition patterns. Conclusion: French children with atopic dermatitis show IgE antibodies to turnip rape, oilseed rape and mustard similarly to the Finnish children. 2S albumin allergens in the seeds of these plants are highly cross-reactive and therefore, they all could be important sensitizers in children with atopic dermatitis. [source]

Insulin resistance and the metabolic syndrome in obese French children

CLINICAL ENDOCRINOLOGY, Issue 6 2006
Céline Druet
Summary Objective, To estimate the frequency of the metabolic syndrome (MS) and of the insulin resistance syndrome (IRS) in overweight or obese French children and to determine the risk factors. Design, patients and methods, A total of 308 overweight and obese children [166 girls, 142 boys, aged 7,17 years; median body mass index (BMI) 4·7 standard deviation (SD) (Q1,Q3: 3·9,5·8) adjusted for age and sex] were included. The frequency of the MS was assessed with the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) criteria and the frequency of the IRS with World Health Organization (WHO) criteria. Results, The overall frequency of MS and IRS was 15·9% and 42·5%, respectively. The most common component, after abdominal obesity (95·8%) and IR (71·8%), was elevated systolic blood pressure (28·6%). The frequency of glucose tolerance disorders was low (3·6%). The frequency of MS was independently influenced by homeostatic model assessment (HOMA) (P = 0·06) and waist-to-hip ratio (P = 0·09), whereas the frequency of IRS was influenced by adiposity (degree of obesity: P = 0·02; waist-to-hip ratio: P = 0·05), puberty (P = 0·05) and mother's BMI (P = 0·01). Ethnicity had no effect on either MS or IRS. Conclusions, Metabolic complications and IR are frequent in overweight and obese children whereas the frequency of glucose tolerance disorders is very low. IRS is more prevalent than MS, indicating a major role of IR, which could precede the other metabolic complications in obese children. IRS is a relevant marker for the risk of type 2 diabetes (T2D) and cardiovascular complications in obese European children. [source]